Aggregated price index with volume information
Summary:
- Pharmaceuticals: Other stocks up 2.0% on average while median return up 1.8% in a day
- Pharmaceuticals: Other stocks up 3.1% on average while median return up 1.9% in a week
- Pharmaceuticals: Other stocks up 10.9% on average while median return up 10.1% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are $RVNC 67.5%, $VRNA 54.7%, $SIGA 34.5%, $INNV 32.6%, $KALV 30.8%
- 1M losers are : Losers for past month are $BHC -11.8%, $RGLS -12.7%, $BRBR -13.0%, $SAVA -19.6%, $PCRX -27.5%
- 1W winners are : Winners for past week are $SAVA 48.0%, $SIGA 12.8%, $COLL 11.5%, $RVNC 8.0%, $INVA 7.9%
- 1W losers are : Losers for past week are $ICLR -1.9%, $HROW -2.3%, $EGRX -2.6%, $SAGE -10.6%, $BHC -21.2%
Correlation Analysis
Index correlation analysis
Correlation for the past month is 11.1%, for the past 3 months is 7.4%
In the past month for a 5 days rolling window, the highest corrrelation is 22.5%, the lowest correlation is 0.6%, the latest correlation is 18.5%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 69.3% between AXSM and IRWD
The lowest correlation is -67.7% between HZNP and ICPT
The Zacks Medical - Services industry is growing on nursing care market growth and digital healthcare adoption. ICLR, OGN and DOCS are set to gain the most. Healthcare staffing shortages are leading to an increase in labor wages.
Sage Therapeutics, Biogen Agenus and BioMarin Pharmaceutical are part of the Zacks top Analyst Blog.
Investors need to pay close attention to United Therapeutics (UTHR) stock based on the movements in the options market lately.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
ICON's (ICLR) second-quarter 2024 results reflect efficient service delivery and strong cost control.
ICON ( NASDAQ:ICLR ) Second Quarter 2024 Results Key Financial Results Revenue: US$2.12b (up 4.9% from 2Q 2023). Net...
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the election of a new independent director, Laura Hamill, to its Board of Directors. Ms. Hamill, a 35-year veteran of the pharmaceutical industry brings broad executive leadership and global commercial operations expertise to the company's Board. Ms. Hamill's election follows the appointment of Patrick Kennedy earlier this year and reflects Jazz's continued focus on Board renewal. At the Annual General meeting held today, shareholders not o
BOSTON, July 25, 2024--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced it will host its second quarter 2024 investor update conference call and webcast at 8:30 a.m. Eastern Time on Thursday, August 8, 2024. Individuals interested in participating in the call should dial (888) 596-4144 (U.S. and Canada) or (646) 968-2525 (international) using conference ID number and event passcode 2530602. To access the webcast, please visit the Investors section of Ironwood’s website at www.ironwo
PTC Therapeutics (PTCT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neurocrine (NBIX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.